Median Technologies SA (EPA:ALMDT)

Market Cap	188.01M +304.3%
Revenue (ttm)	23.47M +2.2%
Net Income	-34.07M
EPS	-0.93
Shares Out	38.14M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	301,753
Average Volume	258,765
Open	4.975
Previous Close	4.930
Day's Range	4.900 - 5.240
52-Week Range	1.192 - 7.270
Beta	0.57
RSI	54.35
Earnings Date	Apr 23, 2026

About Median Technologies

Median Technologies SA engages in providing medical imaging products and services for diagnosing and monitoring cancer patients in both routine clinical practice and clinical drug development with operations spanning in France, the United States, Canada, the United Kingdom, China, and internationally. The company offers iSee for imaging services in clinical trials; eyonis for non-invasive diagnostic tests based on imaging for the diagnosis and treatment of patients suffering from cancer; and iCRO, a central imaging service and AI-powered Imagin...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2002
• Employees: 199
• Stock Exchange: Euronext Paris
• Ticker Symbol: ALMDT

Financial Performance

In 2025, Median Technologies's revenue was 23.47 million, an increase of 2.22% compared to the previous year's 22.96 million. Losses were -34.07 million, 35.0% more than in 2024.